Norbert Wild

Title: Innovating Cancer Detection: The Patented Work of Norbert Wild

Introduction: Norbert Wild, an accomplished inventor based in Geretsried/Gelting, Germany, has made significant contributions to the medical field with a total of five patents to his name. His work primarily focuses on innovative methods for the assessment and detection of cancer and rheumatoid arthritis, showcasing his commitment to advancing healthcare technologies.

Latest Patents: Among his latest innovations, Norbert's work on "Secernin-1 as a Marker for Cancer" stands out. This patent discloses a method that uses the secernin-1 protein (SCRN1) as a universal marker for assessing various types of cancer. The technique involves measuring SCRN1 levels from a liquid sample derived from the individual, which can aid in the early detection of cancer or in monitoring patients post-surgery.

Additionally, he has developed a method to assess the severity of rheumatoid arthritis by measuring anti-cyclic citrullinated peptides (anti-CCP) and serum amyloid A. This assessment involves calculating a combined value based on the concentrations of these markers and comparing it to a predetermined cut-off value derived from a reference population. Furthermore, the method may include additional markers such as C-reactive protein (CRP) and interleukin 6 (IL-6), enhancing the assessment's accuracy.

Career Highlights: Currently, Norbert Wild is affiliated with Roche Diagnostics Operations, Inc., where he collaborates with like-minded professionals to integrate his innovative methods into practical diagnostics. His expertise in developing groundbreaking assessment techniques has positioned him as a key player in transforming the landscape of medical diagnostics.

Collaborations: Throughout his career, Norbert has worked alongside notable colleagues, including Johann Karl and Veit Peter Grunert. These collaborations have fostered a creative environment, allowing for the exchange of ideas that drive innovation within their field.

Conclusion: With a passion for innovation and a track record of impactful patents, Norbert Wild exemplifies the spirit of invention in the medical sector. His contributions to cancer and rheumatoid arthritis detection demonstrate how dedicated inventors can significantly enhance healthcare outcomes through their inventions. The ongoing development of his patented methods continues to inspire and pave the way for future advancements in medical diagnostics.